Longevity Health (XAGEW) Stock Analysis

What Longevity Health does

Longevity Health Holdings Inc. is dedicated to advancing plasma-derived bioactive materials (PBMs) designed to stimulate tissue regeneration and recovery following injuries, illnesses, or age-related decline. Their primary product in development, CT-101, functions both as an accelerant for bone healing—with intended uses including the repair of tibia fractures, facilitating foot and ankle fusions, aiding spinal fusions, substituting for dental bone grafts, and filling bone voids—and as a tissue healing accelerator for conditions such as androgenetic alopecia and persistent wounds. This company was established in 2008 and is based in Pittsburgh, Pennsylvania.

Key metrics

ETFs linked to XAGEW

Broad-market and Healthcare sector ETFs an investor holding Longevity Health is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how XAGEW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Longevity Health?

Longevity Health trades under the ticker XAGEW on NASDAQ.

Which exchange is XAGEW listed on?

XAGEW is listed on NASDAQ.

What sector does Longevity Health operate in?

Longevity Health is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze XAGEW in a portfolio?

PortView shows XAGEW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.